Mutated genes for the catalytic protein of oplophorus luciferase and use thereof
Secreted luciferases which are different from those known heretofore have been desired. The present invention provides a luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2.
1. A recombinant polynucleotide comprising a gene encoding a luciferase mutant having a luciferase activity, wherein said luciferase mutant is selected from the group consisting of:
(a) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2;
(b) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ. ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 is an amino acid sequence in which 1 to 17 amino acids are deleted, substituted, inserted and/or added in the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2; and
(c) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 has at least 90% identity to the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2.
2. The polynucleotide according to claim 1 , Wherein the luciferase mutants defined in (b) to (c) above are mutants defined in (b-1) to (c-1) below:
(b-1) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 is an amino acid sequence in which 1 to 9 amino acids are deleted, substituted, inserted and/or added in the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2; and
(c-1) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 has at least 95% identity to the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2.
3. The polynucleotide according to claim 1 , wherein the luciferase mutant defined in (a) above consists of an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8 and SEQ ID NO: 10.
4. A recombinant vector comprising the polynucleotide according to claim 1 .
5. A transformant transformed with the recombinant vector according to claim 4 .
6. A method for producing the luciferase mutant comprises the steps of culturing the transformant of claim 5 and producing the luciferase mutant.
7. A kit comprising at least one selected from the group consisting of the polynucleotide according to claim 1 , the recombinant vector comprising the polynucleotide, and the transformant transformed with the vector.
8. The kit according to claim 7 , further comprising a luciferin.
9. The kit according to claim 8 , wherein the luciferin is coelenterazines.
10. The kit according to claim 9 , wherein the coelenterazines is bis-coelenterazine or 6h-f-coelenterazine.